Kilroy Realty Corporation is a self administered real estate investment trust active in premier office life science and mixed use property types in the United States. The company owns develops acquires and manages real estate assets consisting primarily of premier office and life science properties in the San Francisco Bay Area Los Angeles Seattle San Diego and Austin. It qualifies as a REIT under the Internal Revenue Code and conducts substantially all of its operations…
Kilroy Realty Corporation is a self administered real estate investment trust active in premier office life science and mixed use property types in the United States. The company owns develops acquires and manages real estate assets consisting primarily of premier office and life science properties in the San Francisco Bay Area Los Angeles Seattle San Diego and Austin. It qualifies as a REIT under the Internal Revenue Code and conducts substantially all of its operations through its operating partnership.
The company generates revenue primarily from rental income and other property income derived from leasing its office life science and mixed use assets. It also earns income from development and redevelopment activities when properties are completed and leased.
The company operates through the following segments:
• Its single reportable segment includes the ownership development acquisition and management of premier office life science and mixed use properties across its core markets.
Kilroy Realty Corporation holds a competitive position in the office and life science sectors due to its focus on high barrier to entry markets such as the San Francisco Bay Area Los Angeles Seattle San Diego and Austin. The company is recognized for its sustainability leadership earning GRESB 5 Star designation and multiple ENERGY STAR certifications. It competes with other developers owners operators and acquirers of similar properties in the same submarkets.
The company serves technology life science healthcare media and business services companies with technology firms representing about half of its office rental income. Its tenant base includes software social media hardware cloud computing internet media and life science and healthcare organizations.
Sector:Real EstateSector rationaleKilroy Realty is a real estate investment trust (REIT) that generates its revenue primarily from rental income derived from owning, developing, and managing office and life science properties. While it serves tenants in the technology and healthcare sectors, its business model is based on leasing physical real property, which falls squarely within the Real Estate sector.Industry:Office REITsReal EstatePrimaryKilroy Realty is a REIT that primarily owns and operates premier office and life science properties. Its revenue is derived from leasing these assets to technology, media, and business services companies.Classified using BQ-MICSCIK: 0001025996
Investment Thesis
▲ Bull case
Kilroy Realty Corporation is uniquely positioned to capitalize on the structural shift toward AI-driven office demand in the Bay Area, which is not merely a temporary rebound but a secular trend underpinning long-term occupancy and rent growth. Management highlighted that San Francisco's AI ecosystem has created considerable new business formation and growth, with companies seeking to utilize AI to enhance growth rather than simply automate for cost savings. This is evidenced by the rapid expansion of tenants like Harvey AI, which leased 93,000 square feet at 201 Third in 2025 and then expanded by an additional 62,000 square feet just one quarter later, with occupancy commencing in April 2026—a pace indicating confidence in sustained business scaling. The company has successfully captured outsized market share at 201 Third through a disciplined spec suites program, with all five recently constructed spec suites leased by completion, demonstrating strong absorption velocity and pricing power. Furthermore, market conditions in San Francisco continue to tighten, with Q1 leasing exceeding 3 million square feet—more than 10% above pre-pandemic quarterly averages—resulting in three consecutive quarters of positive net absorption. This environment allows Kilroy to achieve meaningful rent growth, as seen at Crossing 900 where cash rent spreads are up nearly 60% since 2023, and positions the company to benefit from the flight-to-quality dynamic where tenants prioritize amenitized, transit-oriented, and walkable submarkets like SoMa, Redwood City, and Denny Regrade. The strength in these core markets is not cyclical but rooted in enduring demand from innovation-sector tenants who value proximity to talent pools and infrastructure, providing a durable foundation for rental rate escalation and occupancy improvement beyond current guidance.
The company's proactive capital recycling strategy is creating a more durable and higher-quality portfolio, with dispositions of non-core assets funding accretive investments that enhance long-term cash flow stability and growth. Kilroy has executed approximately $980 million in land and operating property dispositions or contracts over the last two and a half years, redeploying roughly $765 million into four high-caliber infill, amenitized, multi-tenant projects, including the 1900 Broadway joint venture in Downtown Redwood City. This strategic shift has made Kilroy a net seller of approximately $215 million, allowing for debt reduction and opportunistic share repurchases—$73 million bought back at an average price of $30.80 per share in Q1—while simultaneously upgrading the portfolio's quality and location profile. The 1900 Broadway project, already 60% pre-leased to a top-tier global law firm at the highest rates ever realized in the portfolio, is expected to deliver stabilized yields in the low to mid-9% range, with the company's equity investment effectively prefunded through land parcel sales under contract. Additionally, the disposition of non-strategic residential assets in Hollywood and underperforming office properties like Kilroy Sabre Springs and Del Mar Tech Center has eliminated drag on profitability, with proceeds enabling a more balanced capital allocation approach. By prioritizing balance sheet strength and financial flexibility while recycling capital into walkable, amenitized, supply-constrained assets, Kilroy is transforming its portfolio into one that is less vulnerable to broad office market downturns and better positioned to capture sector-specific growth in life sciences, technology, and professional services. This operational de-risking, combined with embedded growth from signed-but-not-commenced leases representing nearly $78 million of annualized base rent, provides a clear pathway to exceed current FFO guidance of $3.49 to $3.63 per share.
Embedded growth from life sciences and secondary market expansion is underappreciated, with KOP2 and Los Angeles assets showing resilience and upside potential that could drive NOI growth beyond current expectations. KOP2 in South San Francisco continues to outperform the broader market, with purpose-built life science space and top-tier amenities driving higher tenant execution propensity; subsequent to quarter end, a 38,000 square foot lease with Olema Pharmaceuticals brought the project to 49% leased, with a robust pipeline including large-format users for the remaining full-building opportunity featuring premium views and prominent location. Management confirmed that mid-5% yield expectations for KOP2 remain intact, indicating stable, long-term cash flow from a sector less susceptible to broad office market volatility. In Los Angeles, trailing twelve-month leasing productivity is up approximately 66%, reflecting both gradual market improvement and significant portfolio repositioning over the last two years. Assets like Maple Plaza in Beverly Hills are experiencing strong, broad-based demand from financial services, media, and entertainment sectors, surpassing original expectations, while Arrow in Long Beach benefits from a resurgence in defense and aerospace requirements. The company's disciplined spec suite program is also gaining traction in LA, San Diego, Austin, and Seattle, driving faster occupancy and higher lease rates. These secondary and niche market strengths—life sciences in KOP2, defense/aerospace in Long Beach, and diversified demand in Beverly Hills—provide diversification away from pure San Francisco tech exposure and offer counter-cyclical stability. With cash same property NOI growth now guided to 25 to 125 basis points (up 150 basis points at the midpoint from prior range), driven by the $5.9 million 23andMe settlement and strengthening core operations, Kilroy has multiple levers to push NOI growth toward the top end of its range, especially as occupancy improvements in core markets compound over time.
Kilroy Realty Corporation is uniquely positioned to capitalize on the structural shift toward AI-driven office demand in the Bay Area, which is not merely a temporary rebound but a secular trend underpinning long-term occupancy and rent growth. Management highlighted that San Francisco's AI ecosystem has created considerable new business formation and growth, with companies seeking to utilize AI to enhance growth rather than simply automate for cost savings. This is evidenced by the rapid expansion of tenants like Harvey AI, which leased 93,000 square feet at 201 Third in 2025 and then expanded by an additional 62,000 square feet just one quarter later, with occupancy commencing in April 2026—a pace indicating confidence in sustained business scaling. The company has successfully captured outsized market share at 201 Third through a disciplined spec suites program, with all five recently constructed spec suites leased by completion, demonstrating strong absorption velocity and pricing power. Furthermore, market conditions in San Francisco continue to tighten, with Q1 leasing exceeding 3 million square feet—more than 10% above pre-pandemic quarterly averages—resulting in three consecutive quarters of positive net absorption. This environment allows Kilroy to achieve meaningful rent growth, as seen at Crossing 900 where cash rent spreads are up nearly 60% since 2023, and positions the company to benefit from the flight-to-quality dynamic where tenants prioritize amenitized, transit-oriented, and walkable submarkets like SoMa, Redwood City, and Denny Regrade. The strength in these core markets is not cyclical but rooted in enduring demand from innovation-sector tenants who value proximity to talent pools and infrastructure, providing a durable foundation for rental rate escalation and occupancy improvement beyond current guidance.
The company's proactive capital recycling strategy is creating a more durable and higher-quality portfolio, with dispositions of non-core assets funding accretive investments that enhance long-term cash flow stability and growth. Kilroy has executed approximately $980 million in land and operating property dispositions or contracts over the last two and a half years, redeploying roughly $765 million into four high-caliber infill, amenitized, multi-tenant projects, including the 1900 Broadway joint venture in Downtown Redwood City. This strategic shift has made Kilroy a net seller of approximately $215 million, allowing for debt reduction and opportunistic share repurchases—$73 million bought back at an average price of $30.80 per share in Q1—while simultaneously upgrading the portfolio's quality and location profile. The 1900 Broadway project, already 60% pre-leased to a top-tier global law firm at the highest rates ever realized in the portfolio, is expected to deliver stabilized yields in the low to mid-9% range, with the company's equity investment effectively prefunded through land parcel sales under contract. Additionally, the disposition of non-strategic residential assets in Hollywood and underperforming office properties like Kilroy Sabre Springs and Del Mar Tech Center has eliminated drag on profitability, with proceeds enabling a more balanced capital allocation approach. By prioritizing balance sheet strength and financial flexibility while recycling capital into walkable, amenitized, supply-constrained assets, Kilroy is transforming its portfolio into one that is less vulnerable to broad office market downturns and better positioned to capture sector-specific growth in life sciences, technology, and professional services. This operational de-risking, combined with embedded growth from signed-but-not-commenced leases representing nearly $78 million of annualized base rent, provides a clear pathway to exceed current FFO guidance of $3.49 to $3.63 per share.
Embedded growth from life sciences and secondary market expansion is underappreciated, with KOP2 and Los Angeles assets showing resilience and upside potential that could drive NOI growth beyond current expectations. KOP2 in South San Francisco continues to outperform the broader market, with purpose-built life science space and top-tier amenities driving higher tenant execution propensity; subsequent to quarter end, a 38,000 square foot lease with Olema Pharmaceuticals brought the project to 49% leased, with a robust pipeline including large-format users for the remaining full-building opportunity featuring premium views and prominent location. Management confirmed that mid-5% yield expectations for KOP2 remain intact, indicating stable, long-term cash flow from a sector less susceptible to broad office market volatility. In Los Angeles, trailing twelve-month leasing productivity is up approximately 66%, reflecting both gradual market improvement and significant portfolio repositioning over the last two years. Assets like Maple Plaza in Beverly Hills are experiencing strong, broad-based demand from financial services, media, and entertainment sectors, surpassing original expectations, while Arrow in Long Beach benefits from a resurgence in defense and aerospace requirements. The company's disciplined spec suite program is also gaining traction in LA, San Diego, Austin, and Seattle, driving faster occupancy and higher lease rates. These secondary and niche market strengths—life sciences in KOP2, defense/aerospace in Long Beach, and diversified demand in Beverly Hills—provide diversification away from pure San Francisco tech exposure and offer counter-cyclical stability. With cash same property NOI growth now guided to 25 to 125 basis points (up 150 basis points at the midpoint from prior range), driven by the $5.9 million 23andMe settlement and strengthening core operations, Kilroy has multiple levers to push NOI growth toward the top end of its range, especially as occupancy improvements in core markets compound over time.
Despite positive leasing momentum in select markets, Kilroy Realty Corporation faces significant near-term occupancy headwinds from a large concentration of 2026 lease expirations that could undermine reported metrics and guidance, particularly as move-outs are expected to dominate the remaining expiration pool. Management acknowledged that the blended retention rate on the initial almost 2 million square foot pool of 2026 expirations was about 40%, and for modeling, the bulk of the remaining 740,000 square feet set to expire in 2026 will be move-outs. Q2 is anticipated to be the biggest move-out quarter during 2026, which could pressure occupancy and same-property NOI in the near term, even if new leasing activity remains strong. While the company has increased full-year average occupancy guidance by 25 basis points at the midpoint, this improvement may be difficult to sustain if move-outs outpace new leasing and commencements, especially given that leases signed but not yet commenced—while representing nearly $78 million of annualized base rent—do not contribute to current occupancy or NOI until they begin. The occupancy drag from expirations could mask the underlying strength in new leasing, leading to potential volatility in quarterly results and investor skepticism about the durability of the recovery. Furthermore, the reliance on markets like San Francisco for growth exposes the company to idiosyncratic risks, such as potential shifts in AI investment cycles or remote work persistence, which could disproportionately affect demand in its core Bay Area portfolio. Although life sciences and LA assets offer diversification, their contribution to overall NOI remains smaller compared to the dominant San Francisco exposure, meaning that any softening in the innovation sector could have an outsized impact on consolidated performance before secondary markets fully compensate.
Despite positive leasing momentum in select markets, Kilroy Realty Corporation faces significant near-term occupancy headwinds from a large concentration of 2026 lease expirations that could undermine reported metrics and guidance, particularly as move-outs are expected to dominate the remaining expiration pool. Management acknowledged that the blended retention rate on the initial almost 2 million square foot pool of 2026 expirations was about 40%, and for modeling, the bulk of the remaining 740,000 square feet set to expire in 2026 will be move-outs. Q2 is anticipated to be the biggest move-out quarter during 2026, which could pressure occupancy and same-property NOI in the near term, even if new leasing activity remains strong. While the company has increased full-year average occupancy guidance by 25 basis points at the midpoint, this improvement may be difficult to sustain if move-outs outpace new leasing and commencements, especially given that leases signed but not yet commenced—while representing nearly $78 million of annualized base rent—do not contribute to current occupancy or NOI until they begin. The occupancy drag from expirations could mask the underlying strength in new leasing, leading to potential volatility in quarterly results and investor skepticism about the durability of the recovery. Furthermore, the reliance on markets like San Francisco for growth exposes the company to idiosyncratic risks, such as potential shifts in AI investment cycles or remote work persistence, which could disproportionately affect demand in its core Bay Area portfolio. Although life sciences and LA assets offer diversification, their contribution to overall NOI remains smaller compared to the dominant San Francisco exposure, meaning that any softening in the innovation sector could have an outsized impact on consolidated performance before secondary markets fully compensate.